Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add filters








Type of study
Language
Year range
1.
Braz. j. infect. dis ; 12(4): 263-263, Aug. 2008.
Article in English | LILACS | ID: lil-496761

ABSTRACT

Hyperamylasemia is a common complication during lamivudine use. We report a case of a pancreatitis following lamivudine therapy. A careful monitoring of amylase levels during treatment with lamivudine is discussed, mainly in the first weeks, considering the cost of this exam and further complication.


Subject(s)
Humans , Male , Middle Aged , Hyperamylasemia/chemically induced , Lamivudine/adverse effects , Pancreatitis/chemically induced , Reverse Transcriptase Inhibitors/adverse effects , Acute Disease , Hepatitis B, Chronic/drug therapy , Lamivudine/therapeutic use , Pancreatitis/enzymology , Reverse Transcriptase Inhibitors/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL